Garden City, N.Y.-based Ophthalmic Consultants of Long Island's Eric Donnenfeld, MD, used EyePoint Pharmaceutical's single-dose postoperative steroid Dexycu in a cataract surgery patient.
What you should know:
1. Dexycu is an FDA-approved postoperative steroid designed to simplify the recovery process. Dexycu is single-dose steroid administered at the end of surgery that eliminates the need for a postoperative dosing regimen.
2. Dr. Donnenfeld performed the cataract surgery at Westbury, N.Y.-based Island Eye Surgicenter using Dexycu at its completion.
3. EyePoint is launching Dexycu through a phased rollout, starting with experienced cataract surgeons.
4. EyePoint will make Dexycu available to patients in need of financial assistance through its EyePoint Assist program.